𝔖 Bobbio Scriptorium
✦   LIBER   ✦

DNA methyltransferase expression differs with proliferation in childhood acute lymphoblastic leukemia

✍ Scribed by Derya Beyza Sayin; Emin Kürekçi; Halil Gürhan Karabulut; Üstün Ezer; Isik Bökesoy

Publisher
Springer
Year
2009
Tongue
English
Weight
228 KB
Volume
37
Category
Article
ISSN
0301-4851

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Aberrant CD2 expression in precursor-B a
Aberrant CD2 expression in precursor-B acute lymphoblastic leukemia of childhood
✍ Dunphy, Cherie H.; Chu, Jen-Yih 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 221 KB 👁 2 views

Aberrant CD2 expression in childhood precursor-B ALL is rare and has recently been reported with an incidence of 3.6% in a study by Cantu-Rajnoldi et al. [Haematologica 77:384, 19921. There was no association of the CD2 co-expression with other known prognostic factors. Our study represents the seco

Prognostic value of miR-16 expression in
Prognostic value of miR-16 expression in childhood acute lymphoblastic leukemia relationships to normal and malignant lymphocyte proliferation
✍ T. Kaddar; W.W. Chien; Y. Bertrand; M.P. Pages; J.P. Rouault; G. Salles; M. Ffre 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 613 KB

miR-16, a miRNA involved in cell proliferation and apoptosis regulation, may interfere with either oncogenic or tumor-suppressor pathways and is implicated in leukemogenesis. We then explored its expression in 93 childhood acute lymphoblastic leukemia (ALL) cases. A high miR-16 expression was associ

Intermittent combined chemotherapy with
Intermittent combined chemotherapy with doxorubicin in recurrent childhood acute lymphoblastic leukemia
✍ Platt, M. P. Ward ;Mott, M. G. ;Eden, O. B. 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 298 KB

## Abstract A series of 14 children with bone marrow or testicular recurrence of acute lymphoblastic leukemia (ALL) and treated with pulsed combined chemotherapy incorporating doxorubicin is reviewed. All had been previously adequately treated according to established leukemia protocols. Median dis